![F. Michael Yakes](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profile
F.
Michael Yakes worked as a Senior Director at Exelixis, Inc. from 2012 to 2012.
Prior to that, he worked as a Senior Director-Translational Biology at Cleave Therapeutics, Inc. Yakes holds a doctorate degree from Wayne State University (Michigan) and an undergraduate degree from Northern Michigan University.
Former positions of F. Michael Yakes
| Companies | Position | End |
|---|---|---|
| EXELIXIS, INC. | Corporate Officer/Principal | 2011-12-31 |
Cleave Therapeutics, Inc.
 Cleave Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical stage biopharmaceutical company that develops medicine for oncology and neurodegeneration treatment | Corporate Officer/Principal | - |
Training of F. Michael Yakes
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
37
1st degree connections
4
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 4 |
|---|---|
Exelixis, Inc.
 Exelixis, Inc. Pharmaceuticals: MajorHealth Technology Operates as a cancer drug discovery company | Health Technology |
Wayne State University (Michigan)
 Wayne State University (Michigan) Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Northern Michigan University
 Northern Michigan University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cleave Therapeutics, Inc.
Cleave Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical stage biopharmaceutical company that develops medicine for oncology and neurodegeneration treatment | Health Technology |
- Stock Market
- Insiders
- F. Michael Yakes
